Spanish paleoanthropologists say a jawbone found last year is from the oldest known hominin in western Europe.

Genomic analysis shows Polynesians and Micronesians have little genetic relation to Melanesians.

Antioxidants may destabilise tumour growth by starving a 'hypoxia protein' of free radicals.

Interest rates, evolutionary neighbours, antibodies get together and sorting sperm from the chaff.

A Brisbane biomedical scientist has set up an online matching service for researchers. And before you ask, it's aimed at finding professional partners, not romantic ones.

An Australian replication study has strengthened evidence that individuals who inherit a common variant of the serotonin transporter gene 5-HTT are more vulnerable to major depression after adverse events in their lives.

The University of Queensland's multi-million dollar exit from unlisted Brisbane biotech Xenome has led to the establishment of a new $750,000 proof-of-concept fund for reinvestment in commercially viable research projects at UQ's Institute for Molecular Bioscience.

Acrux subsidiary FemPharm has secured a US$13.3 million deal with Californian company Vivus to develop and commercialise its transdermal spray for female sexual dysfunction and menopause.

A protein involved in the detection of the most lethal form of DNA damage and which is also linked with a rare genetic disorder has attracted the largest single slice of the NHMRC's latest project funding round for Queensland.

Strengthening its foothold in the US, ResMed has acquired the Californian manufacturing company, Servo Magnetics Inc (SMI) for about $US32 million ($58.38 million).